Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA. 2022 Apr 5;327(13):1236-1246. doi: 10.1001/jama.2022.2832.
JAMA. 2022.
PMID: 35285853
Free PMC article.
Clinical Trial.